Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and other conditions
Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics
Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform
Corporate Matching $200K Challenge Through December 2020 at ACMG Foundation for Genetic and Genomic Medicine
Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
Invitae launches multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Blueprint Genetics Aims to Automate and Improve Clinical Interpretation Processes with Software That Will Change the Industry
JP Morgan 2019 – Drug pricing, drug development, immunotherapy, cancer moonshot, cell/gene-therapy, …